 |
|
Upcoming Events featuring
National CooperativeRx
|
|
|
RASHRM Annual Conference
October 16, 2012
Rockford, IL
Learn more
|
|
 |
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223
|
|
|
Welcome to Pharmacy Month
October is Pharmacy Month! National CooperativeRx plans on celebrating pharmacy month with a lot of great information regarding drug safety for both you and your participants.
This week, we're highlighting the dangers of over the counter (OTC) drugs. Did you know that 100K Americans are hospitalized each year from NSAIDS like aspirin? A similar drug, acetaminophen (Tylenol), causes 10% of all cases of liver failure. Additionally, antacids contain aluminum and may be linked to Alzheimer's and Parkinson's disease. For more information on the risks associated with OTC drugs, click here, and try to remind your participants that OTC drugs should be taken seriously.
Also, watch your inbox for an invite to attend our upcoming webinar! Our newest webinar will be co-hosted by National CooperativeRx staff Shawn Frederickson and Chris Ralston.
|
|
Fox News. Generic drugmaker Teva has stopped shipping Budeprion XL 300 (the generic version of Wellbutrin XL 300) after an FDA request. The FDA found that the generic version of the antidepressant releases its active ingredients quicker, resulting in a less effective drug with more side effects. (10/4) Full story
|
|
US News. A new breast cancer drug is showing promise. The new drug attacks cancer cells but doesn't release chemotherapy until the drug reaches its target. This results in less toxicity but higher effectiveness. Not yet approved by the FDA, the drug appears to be prolonging life and reducing tumor growth. (10/1) Full story
|
Fox News. Adding to the excitement of new drugs to fight cancer is Stivarga. Stivarga has recently been approved by the FDA for patients with colorectal cancer, and is the second colorectal treatment approved in the last two months. Developed by Bayer HealthCare Pharmaceuticals, the drug was shown to increase the lifespan of patients when compared to a placebo. (9/28) Full Story
|
Chicago Tribune. Are beta-blockers being over-prescribed? New research suggests that the drug makes no difference in people whose heart disease is stable when compared to people with stable heart disease who are not taking a beta-blocker. The drug, meanwhile, can also cause fatigue, depression and nightmares. (Joelving, 10/2) Full Story
|
CBS News. The FDA is warning the public of the dangers of shopping for pharmaceuticals online. Only an approximate 3% of online pharmacies are licensed, with many selling fake drugs, or even drugs with dangerous side effects. (9/28) Full Story
|
Kaiser Health News. Drug coupons often put brand name drugs within the same price range as generic drugs for participants, with many not realizing how much more their insurer is paying on their behalf. This article examines the coupon wars, whether or not coupons should be considered "illegal kickbacks," and the moral hazard surrounding them. (Schultz, 10/1) Full Story
|
|
 |
|
